Back to Results
First PageMeta Content
Nephrology / Gadoteridol / Magnetic resonance imaging / Actuarial science / Pharmacovigilance / Anaphylaxis / Minimisation / Risk / Medicine / Health / Nephrogenic systemic fibrosis


EU PSUR Work Sharing Summary Assessment Report PROHANCE® (Gadoteridol) DK/H/PSUR[removed]P-RMS:
Add to Reading List

Document Date: 2014-03-04 09:54:10

Open Document

File Size: 21,74 KB

Share Result on Facebook

Company

GADOTERIDOL Bracco International B.V. / /

Event

FDA Phase / /

IndustryTerm

medicinal product / cardiopulmonary resuscitation equipment / /

MedicalCondition

anaphylactic reactions / fatal anaphylactic reaction / anaphylactic reaction / nephrogenic systemic fibrosis / CMD / /

MedicalTreatment

cardiopulmonary resuscitation / /

Organization

National Science Foundation / European Union / /

Product

PROHANCE / V08CA04 / V08CA04 ProHance / /

ProgrammingLanguage

EC / /

Technology

MRI / DLP / /

SocialTag